blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2591107

EP2591107 - NUCLEIC ACID APTAMER-BASED DIAGNOSTIC METHODS WITH NOVEL TECHNIQUES FOR SIGNAL ENHANCEMENT [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  14.12.2018
Database last updated on 11.09.2024
FormerExamination is in progress
Status updated on  01.03.2017
Most recent event   Tooltip14.12.2018Application deemed to be withdrawnpublished on 16.01.2019  [2019/03]
Applicant(s)For all designated states
Aptateck Bio Ltd.
7 Golda Meir St.
Weizmann Science Park
74036 Ness Ziona / IL
[2013/20]
Inventor(s)01 / NUSSBAUM, Ofer
Hermann Maas St. 1
76566 Rehovot / IL
 [2013/20]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [2013/20]Vossius & Partner
Siebertstrasse 4
81675 München / DE
Application number, filing date11739164.906.07.2011
WO2011IL00530
Priority number, dateUS20100361611P06.07.2010         Original published format: US 361611 P
[2013/20]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2012004790
Date:12.01.2012
Language:EN
[2012/02]
Type: A2 Application without search report 
No.:EP2591107
Date:15.05.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 12.01.2012 takes the place of the publication of the European patent application.
[2013/20]
Search report(s)International search report - published on:EP12.04.2012
ClassificationIPC:C12N15/115, C12N15/11, G01N33/543
[2013/20]
CPC:
C12N15/115 (EP,US); G01N33/54393 (US); C12Q1/6816 (EP,US);
C12Q1/6825 (EP,US); C12Q1/6876 (US); C12Q1/706 (US);
G01N33/54306 (EP,US); C12N2310/16 (EP,US); C12N2320/10 (EP,US);
G01N2333/49 (US); G01N2333/585 (US); G01N2469/10 (US);
Y02A50/30 (US) (-)
C-Set:
C12Q1/6816, C12Q2525/205, C12Q2565/401 (EP,US);
C12Q1/6825, C12Q2525/205, C12Q2565/401 (US,EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/20]
TitleGerman:AUF NUKLEINSÄUREAPTAMER BASIERENDES DIAGNOSTISCHES VERFAHREN MIT NEUEN VERFAHREN ZUR SIGNALVERSTÄRKUNG[2013/20]
English:NUCLEIC ACID APTAMER-BASED DIAGNOSTIC METHODS WITH NOVEL TECHNIQUES FOR SIGNAL ENHANCEMENT[2013/20]
French:MÉTHODES DIAGNOSTIQUES BASÉES SUR DES APTAMÈRES DE TYPE ACIDE NUCLÉIQUE METTANT EN UVRE DE NOUVELLES TECHNIQUES POUR L'AMÉLIORATION DU SIGNAL[2013/20]
Entry into regional phase01.02.2013National basic fee paid 
01.02.2013Designation fee(s) paid 
01.02.2013Examination fee paid 
Examination procedure01.02.2013Amendment by applicant (claims and/or description)
01.02.2013Examination requested  [2013/20]
14.11.2013Despatch of a communication from the examining division (Time limit: M06)
26.05.2014Reply to a communication from the examining division
01.03.2016Despatch of a communication from the examining division (Time limit: M06)
12.09.2016Reply to a communication from the examining division
20.02.2017Despatch of a communication from the examining division (Time limit: M06)
01.09.2017Reply to a communication from the examining division
07.02.2018Despatch of a communication from the examining division (Time limit: M06)
18.08.2018Application deemed to be withdrawn, date of legal effect  [2019/03]
13.09.2018Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2019/03]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  14.11.2013
Fees paidRenewal fee
30.04.2013Renewal fee patent year 03
24.07.2014Renewal fee patent year 04
29.07.2015Renewal fee patent year 05
26.01.2017Renewal fee patent year 06
30.01.2018Renewal fee patent year 07
Penalty fee
Additional fee for renewal fee
31.07.201606   M06   Fee paid on   26.01.2017
31.07.201707   M06   Fee paid on   30.01.2018
31.07.201808   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[ID]WO0179562  (GILEAD SCIENCES INC [US], et al) [ID] 1,6-11,13,18-29,31,36-39,47-49,51-54,57,60,62,63,67-69 * the whole document * * abstract * * page 6, line 15 - line 28 * * page 16, line 2 - line 6 * * figure 1B * * page 30, line 6 - line 30; example 5 *;
 [XI]WO2005113817  (NANOSPHERE INC [US], et al) [X] 1-4,6-13,18,19,22-27,31,34,36-39,47,49-54,57,60,62,63,68,69 * the whole document * * abstract * * page 5, paragraph 4 - paragraph 5 * * page 7, paragraph 3 - paragraph 4 * * page 10, paragraph 4; figure 8 * * page 14, paragraph 2 - paragraph 3 * * page 16, paragraph 1 * * page 18, paragraph 2 - paragraph 4 * * page 19, paragraph 2 * * page 23, paragraph 4 * * page 43, paragraph l; example 2 * * page 48, paragraph l - page 49, paragraph 1; example 5 * * claims 33, 37-39 * * claims 34-35 * * claims 59-60,66 * [I] 14-16,20,21,28-30,32,33,35,40-42,45,46,48,58,59,64-67,70-73;
 [X]WO2007024676  (NANOSPHERE INC [US], et al) [X] 1,6-13,18,19,23,47-50,53,54,60,62,63,68,69 * the whole document * * abstract * * figure 1 * * claims 1-2,6,11-14 *;
 [X]WO2009070640  (GREAT BASIN SCIENT [US], et al) [X] 1,6-13,18-25,34-40,45-54,57-60,62-73 * the whole document * * abstract * * page 3, paragraph 9 * * page 4, paragraph 12 - paragraph 13 * * page 6, paragraph 22 * * page 7, paragraph 28 * * page 11, paragraph 40 - paragraph 41 * * page 12, paragraph 43 - page 13, paragraph 45 * * page 14, paragraph 49 - paragraph 51 * * page 15, paragraph 53 - page 17, paragraph 60 * * page 28, paragraph 100 * * page 30, paragraph 106 * * claims 1, 4-5 * * claims 12-15 * * claims 16-17 *;
 [A]  - DELAIR T ET AL, "SYNTHESIS AND CHARACTERIZATION OF NUCLEIC ACID-(CO)POLYMER CONJUGATES: APPLICATION TO DIAGNOSTICS", POLYMERS FOR ADVANCED TECHNOLOGIES, WILEY & SONS, BOGNOR REGIS, GB, (19980601), vol. 9, no. 6, doi:10.1002/(SICI)1099-1581(199806)9:6<349::AID-PAT789>3.3.CO;2-A, ISSN 1042-7147, pages 349 - 361, XP000765706 [A] 1 * the whole document * * abstract * * page 358, column r, paragraph l - page 359, column r, paragraph 2; figure 6 *

DOI:   http://dx.doi.org/10.1002/(SICI)1099-1581(199806)9:6<349::AID-PAT789>3.3.CO;2-A
 [A]  - JULIEN BERNARD ET AL, "Water-Soluble Dendrigrafts Bearing Saccharidic Moieties: Elaboration and Application to Enzyme Linked OligoSorbent Assay (ELOSA) Diagnostic Tests", BIOCONJUGATE CHEMISTRY, (20060101), vol. 17, no. 1, doi:10.1021/bc049708j, ISSN 1043-1802, pages 6 - 14, XP055010909 [A] 1 * the whole document * * abstract *

DOI:   http://dx.doi.org/10.1021/bc049708j
by applicantWO0179562
 US6458543
 WO2007117444
 US2009203028
    - LR PABORSKY ET AL., "The Single-Stranded DNA Aptamer-Binding Site of Human Thrombin", J. OF BIOL. CHEM., (1993), vol. 268, pages 808 - 811
    - M SASSANFAR, JW SZOSTAK, "An RNA Motif That Binds ATP", NATURE, (1993), vol. 364, pages 550 - 553
    - MIR M, KATAKIS I, "Aptamers as elements of bioelectronic devices", MOL. BIOSYST., (2007), vol. 3, pages 620 - 622
    - LEVY, M, CATER, SF, ELLINGTON, AD, "Quantum-dot aptamer beacons for the detection of proteins", CHEMBIOCHEM, (2005), vol. 6, pages 2163 - 2166
    - "Aptamers", WILLIAM JAMES, Encyclopedia of Analytical Chemistry, JOHN WILEY & SONS LTD, (2000), pages 4848 - 4871
    - PAI SS, ELLINGTON AD, "Using RNA aptamers and the proximity ligation assay for the detection of cell surface antigens", METHODS MOL. BIOL., (2009), vol. 504, pages 385 - 398
    - ZEESHAN M ET AL., "comparison of different phenotypic methods of detection of methicillin resistance in staphylococcus aureus with the molecular detection of mec-agene", J. COLL. PHYSICIANS., (2007), vol. 17, pages 666 - 70
    - "Aptamers", WILLIAM JAMES, Encyclopedia of Analytical Chemistry, JOHN WILEY & SONS LTD, (2000), pages 4848 - 48716
    - TOMBELLI S ET AL., "Aptamers-based assays for diagnostics, environmental and food analysis", BIOMOL ENG., (2007), vol. 24, pages 191 - 200
    - MICHAEL J. ET AL., "The rational development of molecularly imprinted polymer-based sensors for protein detection", CHEM. SOC. REV., (2011), vol. 40, pages 1547 - 1571
    - RAYMOND U. ET AL., "CMV Antigenemia Following Bone Marrow Transplantation: Risk Factors and Outcomes", THE 2000 AMERICAN SOCIETY FOR BLOOD AND MARROW TRANSPLANTATION, (2000), vol. 17, pages 280 - 288
    - PARAGAS VB, ZHANG YZ, HAUGLAND RP, SINGER VL, "The ELF-97 alkaline phosphatase substrate provides a bright, photostable, fluorescent signal amplification method for FISH", J. HISTOCHEM. CYTOCHEM., (1997), vol. 45, pages 345 - 57
    - KERSTENS HM, PODDIGHE PJ, HANSELAAR AG, "A novel in situ hybridization signal amplification method based on the deposition of biotinylated tyramine", J. HISTOCHEM. CYTOCHEM., (1995), vol. 43, pages 347 - 52
    - PETER BIRNER, BARBARA BACHTIARY ET AL., "Signal-Amplified Colorimetric In Situ Hybridization for Assessment of Human Papillomavirus Infection in Cervical Lesions", MOD. PATHOL., (2001), vol. 14, pages 702 - 709
    - EDMONDS M., BRANCHED RNA, BIOESSAYS, vol. 6, pages 212 - 21
    - CHIEN-HUNG CHEN ET AL., "Quantitative detection of hepatitis B virus DNA in human sera by branched-DNA signal amplification", J. OF VIROLOGICAL METHODS, (1995), vol. 53, pages 131 - 137
    - TAO CHEN ET AL., "Valuation of Quantitative PCR and Branched-Chain DNA Assay for Detection of Hepatitis B Virus DNA in Sera from Hepatocellular Carcinoma and Liver Transplant Patients", J. OF CLINICAL MICROBIOLOGY, (2000), vol. 38, pages 1977 - 1980
    - GILADI H, KETZINEL-GILAD M, RIVKIN L, FELIG Y, NUSSBAUM 0, GALUN E, "Small Interfering RNA Inhibits HBV Replication in Mice", MOLECULAR THERAPY, (2003), vol. 8, pages 769 - 76
    - YUAN LI ET AL., "Ultrasensitive Densitometry Detection of Cytokines with Nanoparticle-Modified Aptamers", CLINICAL CHEMISTRY, (2007), vol. 53, page 6
    - YONG HUANG ET AL., "Electrochemical immunosensor of platelet- derived growth factor with aptamer-primed polymerase amplification", ANALYTICAL BIOCHEMISTRY, (2008), vol. 382, page 22
    - BARRETT D ET AL., "Kinetic Characterization of the Glycosyltransferase Module of Staphylococcus aureus PBP2", J. BACTRIO., (200503), pages 2215 - 2217
    - ZEESHAN M ET AL., "comparison of different phenotypic methods of detection of methicillin resistance in staphylococcus aureus with the molecular detection of mec-a gene", J. COLL. PHYSICIANS. SURG. PAK., (2007), vol. 17, pages 666 - 70
    - DABELSTEEN E, "Cell surface carbohydrates as prognostic markers in human carcinomas", THE JOURNAL OF PATHOLOGY, vol. 179, pages 358 - 369
    - FARRA A ET AL., "Role of outer membrane protein OprD and penicillin-binding proteins in resistance of Pseudomonas aeruginosa to imipenem and meropenem", INT. J. ANTIMICROB. AGENTS, (2008), vol. 31, pages 427 - 33
    - MARUNA ET AL., PHYSIOLOGY AND GENETICS OF PROCALCITONIN PHYSIOL. RES., (2000), vol. 49, pages 57 - 61
    - DONDANA, "Procalcitonin increase after endotoxin injection in normal subjects", J. CLIN. ENDOCRINOL. METAB., (1994), vol. 79, pages 1605 - 1608
    - OLEMPSKA M ET AL., "Detection of tumor stem cell markers in pancreatic carcinoma cell lines", HEPATOBILIARY PANCREAT DIS INT., (2007), vol. 6
    - BALSLEV U ET AL., "An outbreak of borderline oxacillin-resistant Staphylococcus aureus (BORSA) in a dermatological unit", MICROB. DRUG RESIST., (2005), vol. 11, pages 78 - 81
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.